Gevo CFO sells 63,028 shares in planned trade

Gevo, Inc. CFO Agiri Oluwagbemileke Yusuf reported an open-market sale of 63,028 shares of common stock at a weighted average price of $1.3974 per share on December 12, 2026.

Rhea-AI Filing Summary

Gevo, Inc. CFO Agiri Oluwagbemileke Yusuf reported an open-market sale of 63,028 shares of common stock at a weighted average price of $1.3974 per share on December 12, 2026. These sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.

After the sale, Yusuf directly holds 491,116 shares of Gevo common stock and has an additional 24,863.8900 shares held indirectly through a 401(k) plan. The filing does not show any option exercises or derivative transactions, only this net sale of common shares.

Insider Trade Summary 10b5-1

Net Seller: 63,028 shares

Net Sell 2 txns

Insider Agiri Oluwagbemileke Yusuf

Role CFO

Sold 63,028 shs ($88K)

Type	Security	Shares	Price	Value
Sale	Common Stock	63,028	$1.3974	$88K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 491,116 shares (Direct); Common Stock — 24,863.89 shares (Indirect, By 401(k) Plan)

Footnotes (2)

1. F1. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.
2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.370 to $1.475 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 63,028 shares Weighted average sale price: $1.3974 per share Direct holdings after sale: 491,116 shares +2 more

5 metrics

Shares sold 63,028 shares Open-market sale of Gevo common stock

Weighted average sale price $1.3974 per share Sale price for 63,028 shares

Direct holdings after sale 491,116 shares Gevo common stock held directly by CFO after transaction

Indirect 401(k) holdings 24,863.8900 shares Gevo common stock held via 401(k) plan

Sale price range $1.370 to $1.475 per share Range of individual transaction prices within the sale

Key Terms

Rule 10b5-1 trading plan, weighted average price, 401(k) Plan

3 terms

Rule 10b5-1 trading plan financial

"The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

401(k) Plan financial

"nature_of_ownership: By 401(k) Plan"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Gevo (GEVO) disclose for its CFO?

Gevo reported that CFO Agiri Oluwagbemileke Yusuf sold 63,028 shares of common stock. The sale was an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan, rather than a discretionary trade based solely on current market conditions.

At what price did the Gevo (GEVO) CFO sell his shares?

The reported sale used a weighted average price of $1.3974 per share. The shares were sold in multiple transactions at prices ranging from $1.370 to $1.475 per share, as disclosed in the footnote explaining the pricing details.

How many Gevo (GEVO) shares does the CFO hold after this Form 4 filing?

Following the reported sale, the CFO directly holds 491,116 shares of Gevo common stock. In addition, 24,863.8900 shares are held indirectly through a 401(k) plan, giving visibility into both his direct and retirement-plan-related ownership positions.

Was the Gevo (GEVO) CFO sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025. Such plans allow executives to pre-schedule trades, which can reduce the significance of timing as a signal of insider sentiment.

Does the Gevo (GEVO) Form 4 show any option exercises or derivative trades?

No. The Form 4 only reports transactions in common stock, including one open-market sale and a 401(k) holding entry. The derivative section is empty, indicating no reported option exercises, conversions, or other derivative security transactions in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 05:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Agiri Oluwagbemileke Yusuf

(Last) (First) (Middle)

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

BUILDING C, SUITE 310

(Street)

ENGLEWOOD COLORADO 80112

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		S(1)		63,028	D	$1.3974(2)	491,116	D
Common Stock								24,863.89	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.370 to $1.475 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ E. Cabell Massey, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)